The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Women’s Health

A potential non-invasive stool test and novel therapy for endometriosis
Pharma & Human Health

A potential non-invasive stool test and novel therapy for endometriosis

OCT 16, 2024
Mayo scientists developing at-home swab tests for endometrial, ovarian cancer
Oncology

Mayo scientists developing at-home swab tests for endometrial, ovarian cancer

JUL 4, 2024
SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women
Finance

SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women

JUL 1, 2024
The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.
Editor's Choice

The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.

MAY 22, 2024
EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections
Finance

EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections

MAR 1, 2024
Women’s Health: The Next Microbiome Frontier
Editor's Choice

Women’s Health: The Next Microbiome Frontier

FEB 20, 2024
Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies
Finance

Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies

DEC 12, 2023
Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces $14M Series A
Finance

Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces $14M Series A

SEP 28, 2023
Women’s Health in Microbiome Research
Pharma & Human Health

Women’s Health in Microbiome Research

SEP 5, 2023
Treating bladder infections with viruses
Infectious Disease & AMR

Treating bladder infections with viruses

JUL 25, 2023
Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections
Infectious Disease & AMR

Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections

JUN 30, 2023